CAS 15721-05-8
:2,2,4,4,6,6,8-Eptametilciclotetrasilossano
- 1,3,3,5,5,7,7-Heptamethylcyclotetrasiloxane
- 2,2,4,4,6,6,8-Heptamethyl-1,3,5,7,2,4,6,8-Tetroxatetrasilocane
- 2,2,4,4,6,6,8-Heptamethyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane
- 2,2,4,4,6,6,8-Heptamethylcyclotetrasiloxane
- 2,4,4,6,6,8,8-Heptamethyl-1,3,5,7,2,4,6,8-Tetroxatetrasilocan-2-Yl
- Cyclotetrasiloxane, 2,2,4,4,6,6,8-heptamethyl-
- Cyclotetrasiloxane, heptamethyl-
- Heptamethyl-Cyclotetrasiloxan
- Heptamethylcyclotetrasiloxane
- Prezzo più basso
- Prezzo più alto
- Purezza più bassa
- Purezza più alta
- Consegna più veloce
Heptamethylcyclotetrasiloxane
CAS:Applications Heptamethylcyclotetrasiloxane is used in the study of the structure-activity relations of organosiloxanes and the female reproductive system.
References Hayden, J. F., et al.: Toxicol. Appl. Pharmacol., 21, 68 (1972)Formula:C7H22O4Si4Colore e forma:NeatPeso molecolare:282.59Ref: 4Z-C-330007
5mgPrezzo su richiesta10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaHeptamethyl cyclotetrasiloxane
CAS:S09240 - Heptamethyl cyclotetrasiloxane
Formula:C7H22O4Si4Purezza:90%Colore e forma:ClearPeso molecolare:282.589Heptamethylcyclotetrasiloxane
CAS:Heptamethylcyclotetrasiloxane is a medicinal compound that has been found to have anticancer properties. It acts as an inhibitor of kinases, which are proteins that play a key role in cancer cell growth and proliferation. Heptamethylcyclotetrasiloxane has been shown to induce apoptosis (programmed cell death) in cancer cells, making it a potential treatment for various types of tumors. This compound is an analog of other kinase inhibitors and has been tested in both Chinese and human cancer cell lines with promising results. Its ability to inhibit kinases makes it a potential candidate for further development as an anticancer drug.
Formula:C7H21O4Si4Purezza:Min. 95%Peso molecolare:281.58 g/mol





